Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The PRCRP was initiated in 2009 to provide support for cancer research of exceptional scientific merit not addressed by the breast cancer, prostate cancer, lung cancer, and ovarian cancer research programs executed and managed by the Office of the Congressionally Directed Medical Research Programs (CDMRP).
The goal of the PRCRP is to improve quality of life by decreasing the impact of cancer on active duty service members, their families, and the American public. As such, the PRCRP will foster the next generation of cancer research by providing new opportunities to successfully pursue high-impact research for the prevention, detection, and treatment of cancer.
Característiques principals
To be considered for funding, applications for the PRCRP Career Development Award must address at least one of the Topic Areas as directed by Congress. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), kidney or ovarian cancer will not be accepted. The FY18 PRCRP Topic Areas are listed below.
  • Adrenal cancer
  • Melanoma and other skin cancers
  • Bladder cancer
  • Mesothelioma
  • Blood cancers
  • Myeloma
  • Brain cancer
  • Neuroblastoma
  • Colorectal cancer
  • Pancreatic cancer
  • Immunotherapy1
  • Pediatric brain tumors
  • Listeria-based regimens for cancer
  • Stomach cancer
  • Liver cancer
  • Cancer in children, adolescents, and young adults2
  • Lymphoma

    There are four award mechanisms:
  • Impact awards (new): Supports Independent investigators at or above the level of Assistant Professor (or equivalent), to conduct hypothesis-driven, high-impact research.
  • Career Development Awards: Supports independent, early-career investigators to conduct impactful research with the mentorship of an experienced cancer researcher.
  • Idea Award with Special Focus: Supports independent investigators at or above the level of Assistant Professor (or equivalent), to conduct innovative, untested, high-risk/potentially highreward concepts, theories, paradigms, and/or methods in cancer research that are relevant to service members, their families, and other military beneficiaries.
  • Translational Team Science Award: Supports a team of 2-3 PIs, to conduct hypothesis-driven translational studies that are associated with an ongoing or completed clinical trial and are focused on research for the next-phase clinical research.
  • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: cbarnwell@imim.es Ext.: 1670
    Marta López: mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    http://cdmrp.army.mil/funding/prcrp
    Dotació
  • Impact award: $1,000,000
  • Career Development Award: $360,000
  • Idea Award with Special Focus: $400,000
  • Translational Team Science Award: $1,000,000
  • Durada
  • Impact award: 3 years
  • Career Development Award: 3 years
  • Idea Award with Special Focus: 2 years
  • Translational Team Science Award: 4 years
  • AVÍS IMPORTANT
    Pre-Application (Preproposal) deadline:
  • Impact award: 20 June, 2018
  • Career Development Award: 28 August 2018
  • Idea Award with Special Focus: 20 June, 2018
  • Translational Team Science Award: 20 June, 2018
    Application submission is by invitation only. Application deadline: September 26, 2018
  • Arxius

    Arxiu
    FY18-PRCRP-IASF.pdf
    FY18-PRCRP-TTSA.pdf
    FY18-PRCRP-CDA.pdf
    18prcrpreftable.pdf
    FY18-PRCRP-IPA.pdf
    FY18-PRCRP-General ApplicationInstructions.pdf